Skip to main content
Erschienen in: PharmacoEconomics 5/2013

01.05.2013

Consolidated Health Economic Evaluation Reporting Standards (CHEERS) Statement

verfasst von: Don Husereau, Michael Drummond, Stavros Petrou, Chris Carswell, David Moher, Dan Greenberg, Federico Augustovski, Andrew H. Briggs, Josephine Mauskopf, Elizabeth Loder

Erschienen in: PharmacoEconomics | Ausgabe 5/2013

Einloggen, um Zugang zu erhalten

Abstract

Economic evaluations of health interventions pose a particular challenge for reporting. There is also a need to consolidate and update existing guidelines and promote their use in a user friendly manner. The Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement is an attempt to consolidate and update previous health economic evaluation guidelines efforts into one current, useful reporting guidance. The primary audiences for the CHEERS statement are researchers reporting economic evaluations and the editors and peer reviewers assessing them for publication.
The need for new reporting guidance was identified by a survey of medical editors. A list of possible items based on a systematic review was created. A two round, modified Delphi panel consisting of representatives from academia, clinical practice, industry, government, and the editorial community was conducted. Out of 44 candidate items, 24 items and accompanying recommendations were developed. The recommendations are contained in a user friendly, 24 item checklist. A copy of the statement, accompanying checklist, and this report can be found on the ISPOR Health Economic Evaluations Publication Guidelines Task Force website (www.​ispor.​org/​TaskForces/​EconomicPubGuide​lines.​asp).
We hope CHEERS will lead to better reporting, and ultimately, better health decisions. To facilitate dissemination and uptake, the CHEERS statement is being co-published across 10 health economics and medical journals. We encourage other journals and groups, to endorse CHEERS. The author team plans to review the checklist for an update in five years.
Literatur
1.
Zurück zum Zitat Drummond MF, Sculpher MJ, Torrance G, O’Brien J, Stoddart GL. Methods for the economic evaluation of health care programmes. 3rd ed. New York: Oxford University Press; 2005. Drummond MF, Sculpher MJ, Torrance G, O’Brien J, Stoddart GL. Methods for the economic evaluation of health care programmes. 3rd ed. New York: Oxford University Press; 2005.
2.
Zurück zum Zitat Drummond MF, Schwartz JS, Jönsson B, Luce BR, Neumann PJ, Siebert U, et al. Key principles for the improved conduct of health technology assessments for resource allocation decisions. Int J Technol Assess Health Care. 2008;24:244–58.PubMed Drummond MF, Schwartz JS, Jönsson B, Luce BR, Neumann PJ, Siebert U, et al. Key principles for the improved conduct of health technology assessments for resource allocation decisions. Int J Technol Assess Health Care. 2008;24:244–58.PubMed
4.
Zurück zum Zitat Neumann PJ, Stone PW, Chapman RH, Sandberg EA, Bell CM. The quality of reporting in published cost-utility analyses, 1976–1997. Ann Intern Med. 2000;132:964.PubMedCrossRef Neumann PJ, Stone PW, Chapman RH, Sandberg EA, Bell CM. The quality of reporting in published cost-utility analyses, 1976–1997. Ann Intern Med. 2000;132:964.PubMedCrossRef
5.
Zurück zum Zitat Rosen AB, Greenberg D, Stone PW, Olchanski NV, Neumann PJ. Quality of abstracts of papers reporting original cost-effectiveness analyses. Med Decis Mak. 2005;25:424–8.CrossRef Rosen AB, Greenberg D, Stone PW, Olchanski NV, Neumann PJ. Quality of abstracts of papers reporting original cost-effectiveness analyses. Med Decis Mak. 2005;25:424–8.CrossRef
6.
Zurück zum Zitat Turner L, Shamseer L, Altman DG, Schulz KF, Moher D. Does use of the CONSORT Statement impact the completeness of reporting of randomised controlled trials published in medical journals? A Cochrane review. Syst Rev. 2012;1:60.PubMedCrossRef Turner L, Shamseer L, Altman DG, Schulz KF, Moher D. Does use of the CONSORT Statement impact the completeness of reporting of randomised controlled trials published in medical journals? A Cochrane review. Syst Rev. 2012;1:60.PubMedCrossRef
7.
Zurück zum Zitat Drummond MF. A reappraisal of economic evaluation of pharmaceuticals. Science or marketing? Pharmacoeconomics. 1998;14:1–9.PubMedCrossRef Drummond MF. A reappraisal of economic evaluation of pharmaceuticals. Science or marketing? Pharmacoeconomics. 1998;14:1–9.PubMedCrossRef
8.
Zurück zum Zitat McGhan WF, Al M, Doshi JA, Kamae I, Marx SE, Rindress D. The ISPOR good practices for quality improvement of cost-effectiveness research task force report. Value Health. 2009;12:1086–99.PubMedCrossRef McGhan WF, Al M, Doshi JA, Kamae I, Marx SE, Rindress D. The ISPOR good practices for quality improvement of cost-effectiveness research task force report. Value Health. 2009;12:1086–99.PubMedCrossRef
9.
Zurück zum Zitat Task Force on Principles for Economic Analysis of Health Care Technology. Economic analysis of health care technology. A report on principles. Ann Intern Med. 1995;123:61–70.CrossRef Task Force on Principles for Economic Analysis of Health Care Technology. Economic analysis of health care technology. A report on principles. Ann Intern Med. 1995;123:61–70.CrossRef
10.
Zurück zum Zitat Drummond MF, Jefferson TO. Guidelines for authors and peer reviewers of economic submissions to the BMJ. BMJ. 1996;313:275–83.PubMedCrossRef Drummond MF, Jefferson TO. Guidelines for authors and peer reviewers of economic submissions to the BMJ. BMJ. 1996;313:275–83.PubMedCrossRef
11.
Zurück zum Zitat Gold MR. Cost-effectiveness in health and medicine. New York: Oxford University Press; 1996. Gold MR. Cost-effectiveness in health and medicine. New York: Oxford University Press; 1996.
12.
Zurück zum Zitat Siegel JE, Weinstein MC, Russell LB, Gold MR. Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine. JAMA. 1996;276:1339–41.PubMedCrossRef Siegel JE, Weinstein MC, Russell LB, Gold MR. Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine. JAMA. 1996;276:1339–41.PubMedCrossRef
13.
Zurück zum Zitat Nuijten MJ, Pronk MH, Brorens MJ, Hekster YA, Lockefeer JH, de Smet PA, et al. Reporting format for economic evaluation: Part II: focus on modelling studies. Pharmacoeconomics. 1998;14:259–68.PubMedCrossRef Nuijten MJ, Pronk MH, Brorens MJ, Hekster YA, Lockefeer JH, de Smet PA, et al. Reporting format for economic evaluation: Part II: focus on modelling studies. Pharmacoeconomics. 1998;14:259–68.PubMedCrossRef
14.
Zurück zum Zitat Vintzileos AM, Beazoglou T. Design, execution, interpretation, and reporting of economic evaluation studies in obstetrics. Am J Obstet Gynecol. 2004;191:1070–6.PubMedCrossRef Vintzileos AM, Beazoglou T. Design, execution, interpretation, and reporting of economic evaluation studies in obstetrics. Am J Obstet Gynecol. 2004;191:1070–6.PubMedCrossRef
15.
Zurück zum Zitat Drummond M, Manca A, Sculpher M. Increasing the generalizability of economic evaluations: recommendations for the design, analysis, and reporting of studies. Int J Technol Assess Health Care. 2005;21:165–71.PubMed Drummond M, Manca A, Sculpher M. Increasing the generalizability of economic evaluations: recommendations for the design, analysis, and reporting of studies. Int J Technol Assess Health Care. 2005;21:165–71.PubMed
16.
Zurück zum Zitat Ramsey S, Willke R, Briggs A, Brown R, Buxton M, Chawla A, et al. Good research practices for cost-effectiveness analysis alongside clinical trials: the ISPOR RCT-CEA Task Force report. Value Health. 2005;8:521–33.PubMedCrossRef Ramsey S, Willke R, Briggs A, Brown R, Buxton M, Chawla A, et al. Good research practices for cost-effectiveness analysis alongside clinical trials: the ISPOR RCT-CEA Task Force report. Value Health. 2005;8:521–33.PubMedCrossRef
17.
Zurück zum Zitat Goetghebeur MM, Wagner M, Khoury H, Levitt RJ, Erickson LJ, Rindress D. Evidence and value: impact on decisionmaking—the EVIDEM framework and potential applications. BMC Health Serv Rev. 2008;8:270.CrossRef Goetghebeur MM, Wagner M, Khoury H, Levitt RJ, Erickson LJ, Rindress D. Evidence and value: impact on decisionmaking—the EVIDEM framework and potential applications. BMC Health Serv Rev. 2008;8:270.CrossRef
18.
Zurück zum Zitat Davis JC, Robertson MC, Comans T, Scuffham PA. Guidelines for conducting and reporting economic evaluation of fall prevention strategies. Osteoporos Int. 2010;22:2449–59.PubMedCrossRef Davis JC, Robertson MC, Comans T, Scuffham PA. Guidelines for conducting and reporting economic evaluation of fall prevention strategies. Osteoporos Int. 2010;22:2449–59.PubMedCrossRef
19.
Zurück zum Zitat Petrou S, Gray A. Economic evaluation using decision analytical modelling: design, conduct, analysis, and reporting. BMJ. 2011;342:d1766.PubMedCrossRef Petrou S, Gray A. Economic evaluation using decision analytical modelling: design, conduct, analysis, and reporting. BMJ. 2011;342:d1766.PubMedCrossRef
20.
Zurück zum Zitat Petrou S, Gray A. Economic evaluation alongside randomised controlled trials: design, conduct, analysis, and reporting. BMJ. 2011;342:d1548.PubMedCrossRef Petrou S, Gray A. Economic evaluation alongside randomised controlled trials: design, conduct, analysis, and reporting. BMJ. 2011;342:d1548.PubMedCrossRef
21.
Zurück zum Zitat Husereau D, Drummond M, Petrou S, Carswell C, Moher D, Greenberg D, et al. Consolidated Health Economic Evaluation Reporting Standards (CHEERS)—explanation and elaboration: a report of the ISPOR Health Economic Evaluations Publication Guidelines Task Force. Value in Health (forthcoming). Husereau D, Drummond M, Petrou S, Carswell C, Moher D, Greenberg D, et al. Consolidated Health Economic Evaluation Reporting Standards (CHEERS)—explanation and elaboration: a report of the ISPOR Health Economic Evaluations Publication Guidelines Task Force. Value in Health (forthcoming).
22.
Zurück zum Zitat Moher D, Schulz KF, Simera I, Altman DG. Guidance for developers of health research reporting guidelines. PLoS Med. 2010;7:e1000217.PubMedCrossRef Moher D, Schulz KF, Simera I, Altman DG. Guidance for developers of health research reporting guidelines. PLoS Med. 2010;7:e1000217.PubMedCrossRef
23.
Zurück zum Zitat Moher D, Weeks L, Ocampo M, et al. Describing reporting guidelines for health research: a systematic review. J Clin Epi 2011;64:718–42. Moher D, Weeks L, Ocampo M, et al. Describing reporting guidelines for health research: a systematic review. J Clin Epi 2011;64:718–42.
24.
Zurück zum Zitat Campbell SM, Hann M, Roland MO, Quayle JA, Shekelle PG. The effect of panel membership and feedback on ratings in a two-round Delphi survey: results of a randomized controlled trial. Med Care. 1999;37:964–8.PubMedCrossRef Campbell SM, Hann M, Roland MO, Quayle JA, Shekelle PG. The effect of panel membership and feedback on ratings in a two-round Delphi survey: results of a randomized controlled trial. Med Care. 1999;37:964–8.PubMedCrossRef
Metadaten
Titel
Consolidated Health Economic Evaluation Reporting Standards (CHEERS) Statement
verfasst von
Don Husereau
Michael Drummond
Stavros Petrou
Chris Carswell
David Moher
Dan Greenberg
Federico Augustovski
Andrew H. Briggs
Josephine Mauskopf
Elizabeth Loder
Publikationsdatum
01.05.2013
Verlag
Springer International Publishing AG
Erschienen in
PharmacoEconomics / Ausgabe 5/2013
Print ISSN: 1170-7690
Elektronische ISSN: 1179-2027
DOI
https://doi.org/10.1007/s40273-013-0032-y

Weitere Artikel der Ausgabe 5/2013

PharmacoEconomics 5/2013 Zur Ausgabe